Prevention of Invasive Cervical Cancer in the United States: Past, Present, and Future
Open Access
- 1 September 2012
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 21 (9) , 1402-1408
Abstract
Over the past several decades, invasive cervical cancer (ICC) incidence in the United States has declined dramatically. Much of this decline has been attributed to widespread use of cytology screening followed by treatment of precancerous lesions. Despite available technologies to prevent ICC and screening programs targeting high-risk women, certain populations in the United States experience disproportionately high rates of ICC (e.g., racial/ethnic minorities and rural women). Limited access to and use of screening/follow-up services underlie this disparity. The licensure of the human papillomavirus (HPV) vaccine in 2006 introduced an additional method of ICC prevention. Unfortunately, dissemination of the vaccine to age-eligible females has been lower than expected (32% have received all 3 recommended doses). Decreasing the burden of HPV infection and HPV-related diseases in the United States will require greater dissemination of the HPV vaccine to adolescents and young adults, along with successful implementation of revised ICC screening guidelines that incorporate HPV and cytology cotesting. While a future without ICC is possible, we will need a comprehensive national health care program and innovative approaches to reduce ICC burden and disparities. Cancer Epidemiol Biomarkers Prev; 21(9); 1402–8. ©2012 AACR.Keywords
This publication has 43 references indexed in Scilit:
- Missed clinical opportunities: Provider recommendations for HPV vaccination for 11–12 year old girls are limitedVaccine, 2011
- Human papillomavirus vaccine uptake among 9‐ to 17‐year‐old girlsCancer, 2011
- Knowledge and intention to participate in cervical cancer screening after the human papillomavirus vaccineVaccine, 2011
- Barriers to Follow-Up of an Abnormal Pap Smear in Latina Women Referred for ColposcopyJournal of General Internal Medicine, 2010
- Cervical cancer preventionCancer, 2010
- Predictors of timely follow‐up after abnormal cancer screening among women seeking care at urban community health centersCancer, 2010
- Age-Specific Evaluation of Primary Human Papillomavirus Screening vs Conventional Cytology in a Randomized SettingJNCI: Journal of the National Cancer Institute, 2009
- Acceptance of the HPV vaccine among women, parents, community leaders, and healthcare providers in Ohio AppalachiaVaccine, 2009
- Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing CountriesVaccine, 2008
- Overview of the European and North American studies on HPV testing in primary cervical cancer screeningInternational Journal of Cancer, 2006